课题基金 / 基金详情

Development of novel gene therapy based on the analysis of anti-apoptotic signals in ovarian cancer

Development of novel gene therapy based on the analysis of anti-apoptotic signals in ovarian cancer
基于卵巢癌抗凋亡信号分析的新型基因疗法的开发
批准号:
11470347
负责人:
KONISHI Ikuo
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

KONISHI Ikuo的其他基金

相似基金

相关文献

中文摘要
翻译
在妇科恶性肿瘤中,卵巢癌最常与化疗耐药及预后不良相关。包括顺铂在内的多种抗癌药物的化疗效果是由细胞内凋亡信号介导的。抗凋亡因子,无论是外在的还是内在的,都可能影响化疗效果,并可能导致卵巢癌细胞的化疗耐药。因此,我们的研究目的是分析卵巢癌细胞的抗凋亡信号,并针对这些抗凋亡信号开发新的基因治疗。我们的研究表明,大约一半的卵巢癌在mRNA和蛋白水平上表达LH/hCG受体。在表达LH/hCG受体的卵巢癌细胞系OVCAR3中,hCG通过上调IGF-1抑制顺铂诱导的细胞凋亡。IGF-1还能抑制顺铂诱导的细胞凋亡,IGF-1受体中和抗体可恢复细胞凋亡。Wortmannin是一种磷脂酰肌醇3-激酶抑制剂,可阻断IGF-1的抗凋亡作用。因此,促性腺激素是卵巢癌细胞抗凋亡信号的重要外源性因子。用表达反义IGF-1 mRNA的重组腺病毒治疗可有效恢复顺铂诱导的细胞凋亡。肿瘤抑制基因p53异常存在于半数以上的卵巢癌中。促凋亡bax基因受p53调控,p53异常导致化疗耐药是一种内在的抗凋亡因子。在体外,与顺铂敏感的A2780 (p53野生型)相比,Bax蛋白在顺铂耐药细胞系(如A2780/cDDP (p53突变)和SKOV3 (p53缺失)中表达减弱。我们开发了高表达Bax蛋白的重组腺病毒。通过Bax/腺病毒转染成功诱导Bax蛋白,并在顺铂耐药卵巢癌细胞中获得凋亡效应。因此,腺病毒介导的Bax导入可能是治疗化疗耐药卵巢癌的一种有用的基因疗法。少
英文摘要
Among the gynecological malignant tumors, ovarian carcinoma is most frequently associated with chemoresistance and poor prognosis of the patients. The effect of chemotherapy with various anti-cancer agents including cisplatin is shown to be mediated by intracellular apoptotic signals. Anti-apoptotic factors, either extrinsic or intrinsic, may influence the chemotherapeutic effect, and may result in the chemoresistance of ovarian cancer cells. Therefore, the objective of our study is to analyze the anti-apoptotic signals in ovarian carcinoma cells, and to develop novel gene therapy targeting these anti-apoptotic signals.Our study demonstrated that an approximately half of ovarian carcinomas expressed LH/hCG receptor at both mRNA and protein levels. In ovarian cancer cell line OVCAR3 expressing LH/hCG receptors, hCG inhibited cisplatin-induced apoptosis via up-regulation of IGF-1. IGF-1 also inhibited cisplatin-induced apoptosis and a neutralizing antibody to IGF-1 receptor restored the … More apoptosis. Wortmannin, an inhibitor of phosphatidyl inositol 3-kinase, blocked the anti-apoptotic effect of IGF-1. Therefore, gonadotropin is an important extrinsic factor of anti-apoptotic signal in ovarian cancer cell. Treatment with recombinant adenovirus expressing anti-sense IGF-1 mRNA was effective for restoring the cisplatin-induced apoptosis.Abnormality of p53 tumor suppressor gene is present in more than half of ovarian carcinomas. Pro-apoptotic bax gene is under the regulation of p53, and p53 abnormality resulted in chemoresistance as an intrinsic anti-apototic factor. In vitro, Bax protein expression was attenuated in cisplatin-resistant cell lines such as A2780/cDDP (p53 mutated) and SKOV3 (p53 deleted), compared with cisplatin-sensitive A2780 (p53 wild type). We developed recombinant adenovirus which highly expresses the Bax protein. The Bax protein was successfully induced by treatment with the Bax/adenovirus transfer, and apoptotic effect was obtained in the cisplatin-resistant ovarian cancer cells. Therefore, adenovirus-mediated introduction of Bax may be a useful gene thrapy in the treatment of chemoresistant ovarian carcinomas. Less
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Horiuchi,A., et al.: "Enhancement of antitumor effect of bleomycin"International Journal of Cancer. 88. 640-644 (2000)
Horiuchi,A., et al.:“博来霉素抗肿瘤作用的增强”国际癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuruta,Y., et al: "Combination effect of pro-apoptotic Bax gene transfer"European Journal of Cancer. (印刷中). (2001)
Tsuruta, Y. 等人:“促凋亡 Bax 基因转移的组合效应”,《欧洲癌症杂志》(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimizu,M., et al: "Immunohistochemical detection of the Wilms'tumor gene"International Journal of Gynecdogical Pathology. 19. 158-163 (2000)
Shimizu,M.,等人:“Wilms肿瘤基因的免疫组织化学检测”国际妇科病理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuroda,H., et al.: "Human ovarian surface epithelial (OSE) cells express"International Journal of Cancer. 92. 309-315 (2001)
Kuroda, H. 等人:“人卵巢表面上皮 (OSE) 细胞表达”国际癌症杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Develop of ovarian cancer stem cell specific immunotherapy based on DNA microarray analysis
    • 批准号:
      23659777
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Evolution of ovarian carcinoma cells through peritoneal dissemination ; genome-wide analysis and clinical application.
    • 批准号:
      21390452
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2009
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Analysis of signaling pathways in peritoneal dissemination of ovarian cancer, which leads to investigation for their suppressor reagents.
    • 批准号:
      19390426
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2007
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    Development of a new molecular target therapy for ovarian carcinoma based on the analyses of mechanisms for its peritoneal dissemination
    • 批准号:
      15390502
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2003
    • 负责人:
      KONISHI Ikuo
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: